Jones Financial Companies
NEPH icon

Jones Financial Companies’s Nephros NEPH Stock Holding History

Jones Financial Companies’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$819 Buy
227
+196
+632% +$637 ﹤0.01% 4646
2026
Q1 		$90 Hold
31
– – ﹤0.01% 4643
2025
Q4 		$151 Hold
31
– – ﹤0.01% 4290
2025
Q3 		$138 Hold
31
– – ﹤0.01% 4145
2025
Q2 		$120 Hold
31
– – ﹤0.01% 3943
2025
Q1 		$52 Buy
+31
New +$49 ﹤0.01% 3653

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Jones Financial Companies's NEPH Position: Q2 2026 in Review

Jones Financial Companies increased its Nephros (NEPH) stake by 632% in Q2 2026, buying an estimated $637 and bringing the position to 227 shares worth $819. The position accounts for ﹤0.01% of the portfolio, ranked #4646.

Jones Financial Companies first reported a position in NEPH in Q1 2025 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Jones Financial Companies held 227 shares of Nephros worth $819 as of Q2 2026.
  • Jones Financial Companies bought 196 Nephros shares in Q2 2026, an estimated $637.
  • Nephros made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4646 holding.
  • Jones Financial Companies first reported a position in Nephros in Q1 2025 and has held it in 6 quarters since.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.